| Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic (AIO-YMO-0112) |
|
|
|
Vollpublikation |
2016 |
|
Young Medical Oncologist
|
|
|
| www.karger.com/Article/abstract/446008 |
|
|
| Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP): A prospective German registry in stage IV NSCLC – AIO-TRK-0315 |
|
|
|
Poster |
2016 |
|
Thorakale Onkologie
|
|
|
| www.karger.com/Article/FullText/449050 |
|
|
| ASORS and AIO German Cancer Society. Implementation of G-CSF-guidelines to prevent febrile neutropenia after chemotherapy in patients with lung or breast cancer – second representative sample survey in Germany (AIO-SUP-0215) |
|
|
|
Poster |
2016 |
|
Supportive Therapie
|
|
|
|
|
|
| Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP-0108 |
|
|
|
Vollpublikation |
2016 |
|
Supportive Therapie
|
|
|
| www.sciencedirect.com/science/article/pii/S0959804916321268 |
|
|
| Implementation of G-CSF-guidelines to prevent febrile neutropenia after chemotherapy in patients with lung or breast cancer – second representative sample survey in Germany (AIO-SUP-0215) |
|
|
|
Poster |
2016 |
|
Supportive Therapie
|
|
|
| www.karger.com/Article/FullText/449050 |
|
|
| Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study (AIO-SUP-0108) |
|
|
|
Vollpublikation |
2016 |
|
Supportive Therapie
|
|
|
| www.ejcancer.com/article/S0959-8049(16)32126-8/fulltext |
|
|
| Patientenrekrutierung für drei neue Studien zur Behandlung von Pankreaskrebs gestartet |
|
|
|
Sonstige |
2016 |
|
Pankreaskarzinom
|
|
|
| www.karger.com/Article/PDF/448701 |
|
|
| NEONAX-Studie: Perioperative vs. adjuvante Systemtherapie mit Nab-Paclitaxel/Gemcitabin bei Patienten mit resektablem Adenokarzinom des Pankreas – eine randomisierte Phase-II-Studie (AIO-PAK-0313) |
|
|
|
Sonstige |
2016 |
|
Pankreaskarzinom
|
|
|
| www.springermedizin.de/neonax-studie/9201680 |
|
|
| Randomized controlled phase II trial of S-1 maintenance therapy in Caucasian population with metastatic esophagogastric cancer–the multinational MATEO study |
|
|
|
Abstract |
2016 |
|
Ösophagus-/Magenkarzinome
|
|
|
|
|
|
| Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RAS WT metastatic colorectal cancer |
|
|
|
Abstract |
2016 |
|
Kolon-/Rektum-/Dünndarmtumoren
|
|
|
| academic.oup.com/annonc/article/27/suppl_6/605TiP/2799259 |
|
|
